OTC Markets OTCPK - Delayed Quote USD
RAKOVINA THERAPEUTICS INC (RKVTF)
0.0360
-0.0001
(-0.28%)
As of April 23 at 1:45:29 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 18.25M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Bacha (Jeffrey) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.04 per share. | Direct | 2,000 | Apr 11, 2025 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 637 | Jan 8, 2025 |
| Bacha (Jeffrey) Senior Officer of Issuer | Other at price 0.07 per share. | Direct | 2,100 | Dec 31, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Other at price 0.07 per share. | Direct | 2,100 | Dec 31, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.13 per share. | Direct | 17,490 | Dec 31, 2024 |
| Liggett (Michael) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Direct | 5,200 | Dec 19, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 4,752 | Oct 25, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 2,592 | Oct 21, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 756 | Oct 18, 2024 |
| Bacha (Jeffrey) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.08 per share. | Direct | 2,025 | Oct 3, 2024 |
| Bacha (Jeffrey) Senior Officer of Issuer | Other at price 0.06 per share. | Direct | 2,175 | Jul 2, 2024 |
| De Lucrezia (Alfredo) Director of Issuer | Other at price 0.06 per share. | Direct | 2,175 | Jul 2, 2024 |
| Daugaard (Mads) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.07 per share. | Direct | 1,750 | May 16, 2024 |
Related Tickers
CYCCP Cyclacel Pharmaceuticals, Inc.
4.8700
+1.46%
MNOV MediciNova, Inc.
1.4600
-2.01%
GYRE Gyre Therapeutics, Inc.
9.03
-1.74%
TECH Bio-Techne Corporation
50.68
+1.04%
TCRT Alaunos Therapeutics, Inc.
2.6600
+8.16%
LEXX Lexaria Bioscience Corp.
1.5532
-2.31%
ADVM Adverum Biotechnologies, Inc.
2.9300
+2.81%
ZVSA ZyVersa Therapeutics, Inc.
0.7426
+5.47%
SVA.TO Sernova Biotherapeutics Inc
0.2200
0.00%
DRMA Dermata Therapeutics, Inc.
0.7768
-1.97%